跳至主要内容
临床试验/TCTR20180216002
TCTR20180216002尚未招募2 期

Efficacy of Oral Disintegrating Strip Sildenafil for the Treatment of Erectile Dysfunction: A Prospective, Randomized Trial

The Government Pharmaceutical Organization0 个研究点目标入组 120 人开始时间: 2018年2月16日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 0 N/A (No limit)(—)
性别
Male

入选标准

  • - Patients with erectile dysfunction condition who are ≥ 18 years old.
  • - Sexual intercourse is failed for ≥ 50% of total sexual activities
  • - Erectile dysfunction for ≥ 3 months
  • - Have only one heterosexual partner and have sexual intercourse at least 2 times per month
  • - Agree to participate in this study and sign the informed consent form

排除标准

  • - Any history of contraindication or hypersensitivity to PDE5 inhibitors
  • - Any history of insensitive to PDE5 inhibitor treatment
  • - Erectile dysfunction due to spinal cord injury
  • - History of radical prostatectomy
  • - Having untreated blood glucose > 270 mg/dl
  • - Having untreated hypogonadism
  • - PSA > 4 ng/dl
  • - Presence of abnormal condition in cardiovascular, hepatic, and renal systems which might be compromised by PDE5 inhibitor treatment
  • - Presence of orthostatic hypotension or uncontrolled blood pressure

研究者

相似试验